January 23, 2013
Ben Venue Laboratories Inc. and federal regulators on Tuesday struck a deal in which the company agreed not to resume full drug manufacturing operations at its Ohio plant until proving it has completely fixed problems that led to the plant's voluntary shutdown in November 2011.